ODD scientists and collaborators have published a research paper describing the discovery of a new class of aminoacyl-tRNA synthetase inhibitors, N-Leucinyl benzenesulfonamides.
Dr. Michael Charlton presented a review of literature analyses of the physical properties of antibacterial compounds.
Oxford Drug Design has started work on a new 3.4 Million Euro Horizon 2020 Marie Curie European Training Network - CARTNET, “Combating Antimicrobial Resistance Training Network”.
Oxford Drug DesignOxford Centre for InnovationNew RoadOxfordOX1 1BY
Phone: +44 (0) 1865 261 468